A Post-hoc Comparison of Paliperidone Palmitate to Oral Risperidone During Initiation of Long-acting Risperidone Injection in Patients with Acute Schizophrenia

Lignende værker

• A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia
  af: Coppola, Danielle, et al.
  Udgivet: (2012)
• PM409. Paliperidone Palmitate 3-Monthly vs. 1-Monthly Injectable in Schizophrenia Patients with or without Prior Exposure to Oral Risperidone or Paliperidone
  af: Mathews, Maju, et al.
  Udgivet: (2016)
• Number needed to treat and number needed to harm with paliperidone palmitate relative to long-acting haloperidol, bromperidol, and fluphenazine decanoate for treatment of patients with schizophrenia
  af: Gopal, Srihari, et al.
  Udgivet: (2011)
• Are the Long-Acting Intramuscular Formulations of Risperidone or Paliperidone Palmitate Associated with Post-Injection Delirium/Sedation Syndrome? An Assessment of Safety Databases
  af: Alphs, Larry, et al.
  Udgivet: (2011)
• Expansion of guidance for the day 8 initiation dose of paliperidone palmitate to avoid a missed dose
  af: Samtani, Mahesh N, et al.
  Udgivet: (2013)